MedTrace Logo

The Pericapsular Nerve Block in Total Hip Arthroplasty

NCT04729686 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2025-01-22

No results posted yet for this study

Summary

In order to continue progressing towards outpatient total hip arthroplasty (THA), methods to adequately manage postoperative pain is of paramount importance. The purpose of this study is to quantify the effectiveness of the pericapsular nerve block in total hip arthroplasty in comparison to the fascia iliaca nerve block.

Conditions

  • Hip Osteoarthritis
  • Hip Arthropathy

Interventions

DRUG

Pericapsular Nerve Block

Per Standard Institutional Practice

DRUG

Fascia Iliaca Nerve Block

Per Standard Institutional Practice

Sponsors & Collaborators

  • Rubin Institute for Advanced Orthopedics

    collaborator UNKNOWN

  • LifeBridge Health

    lead OTHER

Principal Investigators

  • Ronald Delanois, MD · LifeBridge Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-09
Primary Completion
2025-12-01
Completion
2025-12-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04729686 on ClinicalTrials.gov